On this #OMFScienceWednesday, we share #MECFS highlights from Stanford Genome Tech Technology Center research conference facebook.com/OpenMedicineFo…

Highlights of this month's #PersonalizedHealth #PH17 Conference written by Raeka Aiyar are now live on Stanford Medicine Scope medical blog. Thanks to the organizers Lars Steinmetz Judith Zaugg @snydershot Russ Altman for a great meeting! scopeblog.stanford.edu/2017/11/17/per…

New blood test could detect #breastcancer quicker than screenings: on our team's collaboration with Intermountain Cancer in using #genomics tech to improve cancer diagnostics buff.ly/2z3GoBA

Happy Thanksgiving everyone! As you prepare, take a moment to consider the amazing biochemistry, physics, and even genomics that are a part of your Thanksgiving dinner: buff.ly/2zoxv9O

So thrilled to share that Unrest has advanced to the next stage of Oscar voting!! There were 170 submissions. Honored to be among these 15 incredible documentaries: deadline.com/2017/12/oscars… Today, our stories are seen and heard! #TimeForUnrest #mecfs

Happy #OMFScienceWednesday! Today we talk about the research of Mike Snyder (Michael Snyder, PhD), chair of Stanford Medicine Genetics and part of the #MECFS Collaborative Research Center at Stanford that we are funding. facebook.com/OpenMedicineFo…

As Xmas nears, it can be an incredibly difficult time for PWME. I’m thinking of all of you, our carers and families for whom I’m so grateful, and our incredible scientists working for us. Gratitude and much love to you all. X

Our Director Ron Davis provides a year-end update on the latest results, challenges, & plans for #MECFS research! x.com/OpenMedF/statu…

Thrilled to launch our #MECFS Collaborative Research Center CFS Research Center and so very grateful for support from Open Medicine Foundation that made it possible! #OMFScienceWednesday x.com/OpenMedF/statu…

Hosted an Unrest house party to show friends how devastating #MECFS is & how urgent the research is. Sign the NIH Funding petition to demand fair funding for this disease: unrest.film/nih-petition #TimeForUnrest

Our first paper of 2018 is in PNASNews: Streamlined circular proximity ligation assay provides high stringency and compatibility with low-affinity antibodies #diagnostics buff.ly/2mOehCb

Happy #OMFScienceWednesday! Today we profile Lars Steinmetz, Co-Director of Stanford Genome Tech, a new addition to the ME/CFS Collaborative Research Center CFS Research Center. Learn more about Dr. Steinmetz’s research and its relevance to #MECFS here: facebook.com/OpenMedicineFo…

Our latest technology for #biomarker detection – a new version of the proximity ligation assay – covered in Technology Networks buff.ly/2mG3RDO

Jon Clardy describing the “unknown unknowns” concept of the unknown pathways that produce unknown natural products - a focus of our network’s research #KSsynbio

Our network member Beth Sattely describing efforts to improve plant fitness - identification of pathways & metabolites involved in pathogen defense published in @nature: ncbi.nlm.nih.gov/pubmed/26352477 #KSsynbio

We are so happy to see this key work published, after many years of work at our Center & with fantastic collaborators Yi Tang Stanford Medicine Chem-H Colin Harvey Maureen Hillenmeyer Marnix Medema GNPN! x.com/fischer_cr/sta…

Ron Davis is now spending 2 days with bio & bioengineering depts at U Texas talking about developing hi tech. He's focusing on ME/CFS. 300 scientists focused, interested, and being blown away, both by the technology and by the enormity of such a major disease being neglected.

On this #OMFScienceWednesday, we have a promising update on the #MECFS #metabolomics validation study we are funding in Dr. Bob Naviaux’s lab UC San Diego ! omf.ngo/2018/02/07/upd…

Our Director Ron Davis giving a seminar to Stanford Medicine Genetics Department about technologies to make molecular & cellular analyses faster & cheaper

Ron Davis now telling Stanford Genetics Department researchers about #MECFS: "Doctors believe nothing is wrong, because all the patient tests come back negative. But that's because they're not doing enough tests."